Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders

NARecruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Anxiety DisordersSpecific PhobiaPanic DisorderAgoraphobiaSocial Anxiety Disorder
Interventions
BEHAVIORAL

Cognitive behavioral therapy with in vivo exposure

CBT will be used as the chosen approach for ADs. The main components will be psychoeducation and to help patients to challenge and change unhelpful cognitive distortions (e.g., thoughts, beliefs, and attitudes) and behaviors (e.g., avoidance), develop emotion regulation strategies (e.g., cognitive reappraisal), and learn coping strategies that target problem-solving. The practice is developed in several sessions that usually last between 10 and 20 sessions. Specifically, the exposure component will be considered as the first-line treatment. During the exposure component, patients will confront themselves over a long period of time, repetitively, with a feared stimulus until distress has decreased significantly by the exposure.In this condition participants will receive CBT treatment and be exposed to in vivo situations.

BEHAVIORAL

Cognitive behavorial therapy with in vivo exposure plus SYMPTOMS-JIT

CBT will be used as the chosen approach for ADs. The main components will be psychoeducation and to help patients to challenge and change unhelpful cognitive distortions (e.g., thoughts, beliefs, and attitudes) and behaviors (e.g., avoidance), develop emotion regulation strategies (e.g., cognitive reappraisal), and learn coping strategies that target problem-solving. The practice is developed in several sessions that usually last between 10 and 20 sessions. Specifically, the exposure component will be considered as the first-line treatment. During the exposure component, patients will confront themselves over a long period of time, repetitively, with a feared stimulus until distress has decreased significantly by the exposure. In this condition participants will receive CBT treatment and be exposed to in vivo situations with the support of SYMPTOMS-JIT.

Trial Locations (1)

12071

RECRUITING

University Jaume I, Castellon

All Listed Sponsors
lead

Universitat Jaume I

OTHER